Post Menopausal Stress Urinary Incontinence
Conditions
Brief summary
the purpose of the study is to investigate the effect of blood flow restriction training on postmenopausal SUI.
Detailed description
We have two groups: control group (A) and experimental group (B) are two matched post-menopausal stress urinary incontinence. Group A will receive PFMT-associated EMG biofeedback, whereas Group B will receive PFMT-associated EMG biofeedback while applying blood flow restriction to the proximal thigh. Our primary outcome measures will be the severity of SUI symptoms, while the secondary outcome measures will involve QOL, self-esteem, patient's global impression of improvement, maximum voluntary isometric contraction (MVIC) of pelvic floor muscles, pelvic floor muscle resting tone, and the endurance of pelvic floor muscles,
Interventions
OTHERpelvic floor muscle training -associated EMG-biofeedback.
The control group will receive pelvic floor muscle training-associated EMG biofeedback for 10 weeks
OTHERblood flow restriction
experimental group will receive Pelvic floor muscle training-associated EMG biofeedback while applying blood flow restriction to the proximal thigh for 10 weeks.
Sponsors
Kafrelsheikh University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. post-menopausal women, defined by the absence of vaginal bleeding for 12 months, 2. body mass index (BMI) \< 30 3. They should have faced at least two leakage episodes each week and fall into the mild to moderate range of urinary incontinence, measured by (ICIQ-UI SF). 4. Two standard questions about stress and urgency UI were used to determine the patient's eligibility.
Exclusion criteria
1. pelvic organ prolapse greater than grade II on Baden-Walker classification system 2. previous treatment for UI or hormone therapy, ongoing urinary tract infections, cognitive or neurological disorder, or inability to perform the proposed procedures. 3. anyone with past or current injuries to the pelvis, hip joint, or spine, as well as those with uncontrolled diabetes, or those with prior experience in pelvic floor muscle training . 4. the presence of uncontrolled hypertension. 5. patients with a history of deep venous thrombosis (DVT), varicose Veins, cardiac disease, or lymphedema.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| severity of stress urinary incontinence (SUI) symptoms. | baseline,10 weeks, 16 weeks | severity of SUI symptoms, measured by the Arabic version of the International consultation on incontinence questionnaire-short form (ICIQ-UI SF) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| self-esteem | baseline,10 weeks, 16 weeks | self-esteem will be measured by Arabic Rosenberg self-esteem scale |
| patient's global impression of improvement | baseline,10 weeks, 16 weeks | patient's global impression of improvement will be measured by Patient Global Impression of Improvement (PGI-I) scale. |
| Quality of life (QOL) | baseline,10 weeks, 16 weeks | QOL will be measured by International consultation on incontinence questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTS qol) |
| pelvic floor muscle resting tone | baseline,10 weeks, 16 weeks | pelvic floor muscle resting tone will be measured by Neurotrac myoplus pro EMG |
| pelvic floor muscle endurance | baseline,10 weeks, 16 weeks | pelvic floor muscle endurance will be measured by Neurotrac myoplus pro EMG |
| maximum voluntary isometric contraction (MVIC) of pelvic floor muscles | baseline,10 weeks, 16 weeks | maximum voluntary isometric contraction (MVIC) of pelvic floor muscles will be measured by Neurotrac myoplus pro EMG |
Contacts
Primary ContactJilan Adel, lecturer
Outcome results
None listed